In a major scientific breakthrough with far-reaching implications for medicine and disease diagnosis, Indian researchers have developed a cutting-edge imaging technology called “CLEAR” that could revolutionise the way scientists study proteins inside cells and tissues.

The new platform, named Cleavable Light-Erased Antibody Reporter (CLEAR), enables researchers to visualise an unprecedented number of proteins within the same biological sample using just a single fluorescent marker — a development that could significantly advance cancer diagnostics, neuroscience research, immunology and precision medicine.

The technology has been developed by researchers at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), an autonomous institute under the Department of Science and Technology (DST).

Scientists say the innovation could help create highly detailed “protein maps” of tissues and cells, potentially allowing doctors and researchers to better understand how diseases such as cancer and neurological disorders develop and spread.

Why Protein Mapping Matters

Proteins are among the most important molecules in the human body. They regulate almost every biological function and serve as key indicators of disease. Most modern medicines are also designed to target specific proteins.

However, scientists have long struggled to comprehensively map proteins within tissues while preserving their exact spatial arrangement — a challenge considered one of the biggest barriers in advanced biological imaging.

Understanding where proteins are located and how they interact inside cells is crucial for:

Detecting cancer at an early stage
Studying tumour microenvironments
Understanding neurological disorders such as Alzheimer’s and Parkinson’s
Analysing immune responses
Designing targeted therapies

Existing imaging techniques face several limitations, including restricted multiplexing capacity, complex workflows and the need for multiple fluorescent markers.

The newly developed CLEAR technology aims to overcome these limitations.

How CLEAR Technology Works

The CLEAR platform introduces an innovative light-cleavable probe system that allows repeated cycles of protein labelling and imaging within the same sample.

Scientists compare the process to using a chalkboard.

Just as writing on a blackboard can be erased to create space for new information, the CLEAR method allows fluorescent signals used for imaging proteins to be removed after every imaging cycle, making room for the next round of protein visualisation.

Step-by-Step Process

The workflow involves:

Proteins inside cells are labelled using special fluorescent tags.
Researchers capture microscopic images of the tagged proteins.
A gentle pulse of 365 nm LED light is applied to erase the fluorescent signal.
A new set of proteins is then labelled and imaged within the same optical window.
The cycle is repeated multiple times to generate highly detailed protein maps.

This repeated erase-and-reimage capability allows scientists to visualise a very large number of proteins in the same sample without requiring multiple fluorophores.

Researchers say this fundamentally redefines multiplexed imaging.

A Major Leap Beyond Existing Imaging Technologies

According to the research team, CLEAR combines several advantages rarely achieved together in existing imaging methods.

The platform offers:

High multiplexing capability
High spatial resolution
Faster imaging cycles
Compatibility with delicate biological samples
Ability to work with live cells
Use of a single fluorophore instead of multiple dyes

This means scientists can generate richer and more detailed biological information while simplifying the imaging process.

The technology is expected to be especially useful in studying complex tissue systems where protein interactions are extremely intricate.

Indian Scientists Behind the Innovation

The research was led by Sarit S. Agasti and his team at JNCASR.

The researchers designed and synthesised the CLEAR probes, developed the imaging workflow and validated the platform across multiple biological systems.

The project also involved collaboration with researchers from the Indian Institute of Science (IISc), particularly for demonstrating the platform in complex immune cell systems.

The findings have been published in the reputed scientific journal Chemical Science.

Potential Game-Changer for Cancer Diagnosis

One of the most promising applications of CLEAR lies in cancer biology.

Tumours often contain highly complex cellular environments with multiple proteins interacting simultaneously. Understanding this spatial organisation is critical for identifying how cancer grows, spreads and responds to treatment.

With CLEAR, researchers may be able to:

Identify tumour biomarkers more accurately
Study cancer progression at cellular resolution
Improve early diagnosis of cancers
Develop more targeted treatment strategies
Understand treatment resistance mechanisms

Pathologists could eventually use detailed protein maps generated through CLEAR to make more precise diagnoses.

Important Implications for Neurological Disorders

The technology could also transform research into neurological diseases.

Brain disorders such as Alzheimer’s disease, Parkinson’s disease and other neurodegenerative conditions involve highly complex protein interactions inside neural tissues.

By enabling comprehensive mapping of proteins within their native environment, CLEAR may help scientists better understand:

Neuronal communication pathways
Protein aggregation in brain disorders
Immune activity in neurological diseases
Cellular degeneration mechanisms

This could potentially accelerate the development of therapies for conditions that currently have limited treatment options.

Boost for Precision Medicine

Experts believe CLEAR aligns closely with global efforts towards precision medicine and spatial proteomics — an emerging field focused on understanding the spatial distribution of proteins within tissues.

Precision medicine aims to develop personalised treatment strategies based on the unique molecular profile of individual patients.

The detailed molecular insights provided by CLEAR could help doctors tailor therapies more effectively, particularly in cancer treatment and immunotherapy.

Significance for Indian Scientific Research

The development of CLEAR also highlights India’s growing capabilities in advanced biomedical research and imaging technologies.

The breakthrough demonstrates the increasing contribution of Indian institutions to globally relevant scientific innovation in areas such as molecular biology, diagnostics and translational medicine.

Researchers believe the platform could eventually become an important tool not only in laboratories but also in future clinical diagnostic systems.

As scientists continue refining the technology, CLEAR could emerge as a powerful next-generation imaging platform capable of changing how diseases are diagnosed, studied and treated across the world.